Khiron Life Sciences Corp (TSXV: KHRN), a Canadian integrated medical cannabis company, has announced on Thursday that it has appointed a former U.S. Drug Enforcement Administration (“DEA”) official as the company’s vice president for compliance.
With the bulk of Khiron’s operations taking place in Colombia, Matt Murphy, who was the DEA’s Chief of Pharmaceutical Investigations, will be dealing with compliance issues in Colombia.
First to hire DEA official
Citing Murphy’s 25 years experience in the DEA, Khiron touted itself for becoming the “only medical cannabis producer in Colombia with DEA-level security protocols.”
Colombia has a warm climate, abundant rainfall and 12 hours of daylight all year, making the Latin American country enjoy natural advantages for growing marijuana.
However, Colombians suffer from high crime rates. Between January and December 1, 2014, Colombia saw over 11,600 murders, according to police statistics accessed by El Tiempo.
Khiron’s Alvaro Torres, President, and CEO, said: “With Mr. Murphy’s leadership, we have developed a scalable and comprehensive compliance and security plan that identifies and mitigates all risks relating to Khiron’s assets, and covers the entire production, distribution, logistics, and operations chain.”
In his new role, Murphy will also oversee the personal security of employees and physical security of all facilities, distribution networks, and logistics.
Murphy will also be working with the former Lieutenant Colonel of the National Police of Colombia, Henry Tibaduiza, who is khiron’s security manager.
Tibaduiza will assume responsibility for developing strong relations with local, regional and national law enforcement and military authorities throughout the country.